查看购物车
  • Traditional Chinese
  • English
封面
市场调查报告书
商品编码
1701878

2025 年至 2033 年干细胞製造市场报告（按产品、应用、最终用户和地区）

Stem Cell Manufacturing Market Report by Product, Application, End User, and Region 2025-2033
出版日期: | 出版商: IMARC | 英文 144 Pages | 商品交期: 2-3个工作天内

价格

2024年全球干细胞製造市场规模达142亿美元。展望未来， IMARC Group预计到2033年市场规模将达到258亿美元，2025-2033年期间的成长率（CAGR）为6.8%。干细胞研究投资的增加、慢性病盛行率的上升、生物技术的进步、学术界和工业界之间的合作、严格的法规以及对干细胞疗法的认识的不断提高正在刺激市场的成长。

干细胞製造市场分析：

  • 主要市场驱动因素：在政府有利措施的支持下，干细胞研究领域的创投不断成长是推动干细胞製造市场发展的主要动力。这反过来反映出人们越来越认识到干细胞在推动医疗保健和再生医学方面的潜力。
  • 主要市场趋势：干细胞製造市场的一些主要趋势包括干细胞研究和再生医学支出的增加、流程自动化、产业参与者之间的合作日益增多以及生物反应器技术的快速进步。
  • 地理趋势：北美在干细胞製造市场处于领先地位，这归因于多种因素，包括领先的生物技术和製药公司的存在、对干细胞製造临床试验和商业化的支持性监管框架、强大的研发（R&D）基础设施，以及该地区对再生医学疗法不断增长的需求。
  • 竞争格局：干细胞製造业的主要市场参与者包括 Anterogen Co. Ltd.、Becton Dickinson and Company、Bio-Rad Laboratories Inc.、Bio-Techne Corporation、Corning Incorporated、FUJIFILM Holdings Corporation、Lonza Group AG、Merck KGaA、Sartorius AG、Takara Bio Inc. 和 The Fisher Scientific. Fisher Scientificent。
  • 挑战与机会：政府推动生物技术和生物製药产业发展的措施为市场带来了重大机会。补助、税收优惠和补贴等措施旨在促进研发、吸引投资、采用先进技术并加速治疗和疗法的科学发现和创新。然而，市场也面临重大挑战，例如与製造规模扩大相关的技术限制，这需要公司专门的设备和基础设施来克服。

干细胞製造市场趋势：

增加对干细胞研究和再生医学的投资

由于大量资金涌入干细胞研究和再生医学，全球干细胞製造市场正在经历显着的成长。政府和私人组织正在向这些领域投入资源，并认识到它们彻底改变医疗保健的潜力。这项驱动力源自于干细胞疗法在治疗神经退化性疾病和脊髓损伤等以前无法治癒的疾病方面的良好前景。例如，2023 年 8 月发表在《新英格兰医学杂誌》上的一篇文章揭示了干细胞基因疗法在治疗镰状细胞疾病 (SCD) 方面的预期潜力。这些投资支持尖端研究、先进製造技术的开发和临床试验的扩展。例如，2021 年 9 月，LifeCell International Pvt. Ltd 从 OrbiMed Asia Partners IV 获得了 225 亿印度卢比（2720 万美元）的投资，以进一步利用其技术专长和广泛的网络进军生育健康和细胞治疗等相邻的新领域。此外，2023 年 11 月，专门从事重组蛋白和必需试剂的美国公司 ACROBiosystems Inc. 推出了 GM 级 DLL4 蛋白，这是 Delta 样配体 4 (DLL4) 的可溶形式，对干细胞的发育和分化至关重要。

慢性病盛行率上升及对创新治疗的需求

推动全球干细胞製造市场发展的另一个重要驱动力是慢性病的日益普及。糖尿病、心臟病和自体免疫疾病等疾病的发生率正在上升，需要新颖有效的治疗方法。干细胞疗法透过再生受损的组织和器官，在治疗这些疾病方面具有巨大的前景。例如，2021 年 3 月，Vertex Pharmaceuticals 获得 FDA 对 VX-880 的快速通道认证，VX-880 是一种针对 1 型糖尿病患者的人类干细胞衍生疗法。此外，根据美国食品药物管理局（FDA）2022年12月提供的资料，美国有超过7,000种罕见疾病，影响超过3,000万人。慢性病的盛行率随着年龄的增长而上升，而干细胞製造在对抗这些疾病方面显示出良好的前景。例如，世界卫生组织 2021 年 10 月的一份情况说明书预测，到 2030 年，全球 65 岁以上人口将达到 14 亿，预计到 2050 年这一数字将翻一番，达到 22 亿。

生物技术和细胞培养技术的进展

生物技术和细胞培养技术的进步正在彻底改变干细胞製造领域。这项驱动因素对于提高干细胞生产的效率和可扩展性至关重要。 3D细胞培养系统和生物反应器等细胞培养技术的突破使得大量培养高品质干细胞成为可能。此外，CRISPR-Cas9 等基因编辑技术的创新可以精确控制干细胞特性，进一步扩大其治疗潜力。这些进步不仅简化了製造流程，而且还确保了干细胞疗法的安全性和质量，从而增强了医疗专业人员和患者的信心。例如，2021 年 9 月，专门从事干细胞製造的美国生物技术公司 Cellino 展示了其係统如何整合人工智慧、机器学习和雷射以及其他硬体和软体，以提高产量并降低生产成本。

干细胞製造市场细分：

按产品分类：

  • 耗材
    • 文化传媒
    • 其他的
  • 仪器
    • 生物反应器和培养箱
    • 细胞分选仪
    • 其他的
  • 干细胞系
    • 造血干细胞（HSC）
    • 间质干细胞（MSC）
    • 诱导性多能干细胞（iPSC）
    • 胚胎干细胞（ESC）
    • 神经干细胞（NSC）
    • 多能成体祖干细胞

耗材占据市场主导地位

由于基于干细胞的研究和治疗的日益普及，干细胞製造市场中的消耗品部分正在经历强劲增长，需要持续供应消耗品，包括细胞培养基、试剂和生长因子。随着该领域研究的不断扩展，对这些必需材料的需求也不断增加。此外，干细胞临床试验和再生医学应用的不断增长也刺激了消耗品的消耗。临床研究和治疗开发需要一致且可靠的高品质耗材来源，以确保基于干细胞治疗的安全性和有效性。与此相符的是，消费品生产技术的进步正在推动成长。

按应用分类：

  • 研究应用
    • 生命科学研究
    • 药物研发
  • 临床应用
    • 同种异体干细胞治疗
    • 自体干细胞治疗
  • 细胞和组织库应用

研究应用主导市场

干细胞製造市场中研究应用部分的成长得益于对科学知识的不懈追求和干细胞生物学的突破性发现。干细胞是研究各种生物过程、疾病机制和潜在治疗途径的重要工具。再生医学、发育生物学和药物开发等不同领域的研究人员都依赖干细胞来推进他们的研究。此外，分配给干细胞研究的资金和补助不断增加，促进了这一领域的成长。政府、私人机构和非营利组织认识到干细胞研究的变革潜力，并提供资金支持以推动创新。此外，干细胞培养技术、基因编辑和细胞表征工具的技术进步提高了研究应用的效率和准确性。这些进步使研究人员能够研究更广泛的干细胞类型并对其进行精确操作，从而进一步扩大研究的可能性范围。例如，2023 年 5 月，Sernova 宣布与阿斯特捷利康进行研究合作，以评估新型潜在治疗细胞应用。

按最终用户分类：

  • 製药和生物技术公司
  • 学术机构、研究实验室和合约研究组织
  • 医院和外科中心
  • 细胞和组织库
  • 其他的

製药和生物技术公司主导市场

全球人口的不断增长和人口老化趋势推动了製药和生物技术公司的成长。随着人口老化，对医疗保健服务、药物和创新疗法的需求不断增加，为製药和生物技术公司提供了庞大的市场。此外，心血管疾病、癌症和糖尿病等慢性疾病的盛行率不断上升，使得持续研究和开发新的药物解决方案成为必要。这些公司在开发先进药物和疗法以应对这些健康挑战方面发挥关键作用。此外，基因治疗、精准医疗和生物製药等生物技术的进步正在塑造这个产业。

按地区划分：

  • 北美洲
    • 美国
    • 加拿大
  • 亚太
    • 中国
    • 日本
    • 印度
    • 韩国
    • 澳洲
    • 印尼
    • 其他的
  • 欧洲
    • 德国
    • 法国
    • 英国
    • 义大利
    • 西班牙
    • 俄罗斯
    • 其他的
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 其他的
  • 中东和非洲

北美占据明显优势，占据最大的干细胞製造市场份额

市场研究报告也对所有主要区域市场进行了全面分析，包括北美（美国和加拿大）；欧洲（德国、法国、英国、义大利、西班牙、俄罗斯等）；亚太地区（中国、日本、印度、韩国、澳洲、印尼等）；拉丁美洲（巴西、墨西哥等）；以及中东和非洲。报告显示，北美占据最大的市场份额。

受政府和私人对干细胞研究和再生医学的大量投资推动，北美地区的干细胞製造市场正在强劲成长。这些资金承诺支持尖端研究、临床试验和先进製造技术的开发。此外，糖尿病、心臟病和神经退化性疾病等慢性病的盛行率在北美呈上升趋势。干细胞疗法为解决这些问题提供了创新的解决方案，从而推动了其生产的需求。与此相符的是，该地区拥有高度发展的生物技术部门，在细胞培养技术和生物加工技术方面取得了重大进展。这确保了高效、可扩展的干细胞生产，巩固了该产业在北美的立足点。此外，北美的监管框架为干细胞研究和临床试验提供了有利的环境，促进了成长和创新。学术机构和产业参与者之间的合作努力以及公众对干细胞治疗潜力的认识不断提高是额外的驱动力。

（请注意，这只是关键参与者的部分列表，完整列表在报告中提供。）

  • 全球干细胞製造市场的竞争格局以众多参与者的动态互动为特征，每位参与者都争相确立自己的地位并为产业成长做出贡献。这些实体涵盖了一系列组织，包括研究机构、生技公司、製药巨头和合约製造组织。他们不同的背景和资源构成了一个多方面的生态系统，促进了干细胞製造的创新和进步。关键竞争策略包括研究和开发工作，以加强製造流程、扩大生产规模以及提高干细胞疗法的品质和安全性。此外，这些参与者之间的伙伴关係和合作也很常见，促进了知识共享和尖端技术的发展。例如，2021 年 6 月，Catalent 采取策略性倡议，以未公开的金额收购了 RheinCell Therapeutics Gmbh，以扩大先进细胞治疗方法的研发，从而增强 Catalent 的大规模生产能力。遵守法规和遵守道德标准对于维护市场信誉至关重要。此外，市场参与者经常参与行销和教育活动，以提高医疗保健专业人员和公众对干细胞疗法的认识，进一步扩大其影响力。

本报告回答的关键问题

  • 2024 年全球干细胞製造市场规模是多少
  • 2025-2033年全球干细胞製造市场的预期成长率是多少
  • 推动全球干细胞製造市场的关键因素有哪些
  • COVID-19 对全球干细胞製造市场有何影响
  • 全球干细胞製造市场依产品划分如何？
  • 根据应用，全球干细胞製造市场如何划分
  • 根据最终用户，全球干细胞製造市场如何分布
  • 全球干细胞製造市场的主要区域有哪些
  • 全球干细胞製造市场的主要参与者/公司有哪些

本报告回答的关键问题

  • 2024 年全球干细胞製造市场规模？ 2025-2033年全球干细胞製造市场的预期成长率是多少？
  • 推动全球干细胞製造市场发展的关键因素有哪些？
  • COVID-19 对全球干细胞製造市场有何影响？
  • 全球干细胞製造市场依产品划分是怎样的？
  • 根据应用，全球干细胞製造市场如何分布？
  • 根据最终用户，全球干细胞製造市场是如何分布的？
  • 全球干细胞製造市场的关键区域有哪些？
  • 全球干细胞製造市场的主要参与者/公司有哪些？

目录

第一章：前言

第二章：范围与方法

  • 研究目标
  • 利害关係人
  • 资料来源
    • 主要来源
    • 次要来源
  • 市场评估
    • 自下而上的方法
    • 自上而下的方法
  • 预测方法

第三章：执行摘要

第四章：简介

  • 概述
  • 主要行业趋势

第五章：全球干细胞製造市场

  • 市场概览
  • 市场表现
  • COVID-19的影响
  • 市场预测

第六章：市场区隔：依产品

  • 耗材
    • 关键部分
      • 文化传媒
      • 其他的
  • 仪器
    • 关键部分
      • 生物反应器和培养箱
      • 细胞分选仪
      • 其他的
  • 干细胞系
    • 关键部分
      • 造血干细胞（HSC）
      • 间质干细胞（MSC）
      • 诱导性多能干细胞（iPSC）
      • 胚胎干细胞（ESC）
      • 神经干细胞（NSC）
      • 多能成体祖干细胞

第七章：市场区隔：依应用

  • 研究应用
    • 关键部分
      • 生命科学研究
      • 药物研发
  • 临床应用
    • 关键部分
      • 同种异体干细胞治疗
      • 自体干细胞治疗
  • 细胞和组织库应用

第八章：市场区隔：按最终用户

  • 製药和生物技术公司
  • 学术机构、研究实验室和合约研究组织
  • 医院和外科中心
  • 细胞和组织库
  • 其他的

第九章：市场细分：依地区

  • 北美洲
    • 美国
    • 加拿大
  • 亚太
    • 中国
    • 日本
    • 印度
    • 韩国
    • 澳洲
    • 印尼
    • 其他的
  • 欧洲
    • 德国
    • 法国
    • 英国
    • 义大利
    • 西班牙
    • 俄罗斯
    • 其他的
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 其他的
  • 中东和非洲
    • 市场区隔：依国家

第十章：SWOT分析

  • 概述
  • 优势
  • 弱点
  • 机会
  • 威胁

第 11 章：价值链分析

第 12 章：波特五力分析

  • 概述
  • 买家的议价能力
  • 供应商的议价能力
  • 竞争程度
  • 新进入者的威胁
  • 替代品的威胁

第十三章：价格分析

第 14 章：竞争格局

  • 市场结构
  • 关键参与者
  • 关键参与者简介
    • Anterogen Co. Ltd.
    • Becton Dickinson and Company
    • Bio-Rad Laboratories Inc.
    • Bio-Techne Corporation
    • Corning Incorporated
    • FUJIFILM Holdings Corporation
    • Lonza Group AG
    • Merck KGaA
    • Sartorius AG
    • Takara Bio Inc.
    • Thermo Fisher Scientific Inc.
Product Code: SR112025A6072

The global stem cell manufacturing market size reached USD 14.2 Billion in 2024. Looking forward, IMARC Group expects the market to reach USD 25.8 Billion by 2033, exhibiting a growth rate (CAGR) of 6.8% during 2025-2033. Increasing investments in stem cell research, rising chronic disease prevalence, advancements in biotechnology, collaborations between academia and industry, stringent regulations, and expanding awareness of stem cell therapies are stimulating the market growth.

Stem Cell Manufacturing Market Analysis:

  • Major Market Drivers: Growing venture capital investment in stem cell research, supported by favorable government initiatives are majorly driving the stem cell manufacturing market. This, in turn, reflects the increasing recognition of stem cell's potential in advancing healthcare and regenerative medicine.
  • Key Market Trends: Some of the key trends in the stem cell manufacturing market include rising expenditure on stem cell research and regenerative medicine, automation of processes, increasing collaborations among industry players, and rapid advancements in bioreactor technology.
  • Geographical Trends: North America is leading the stem cell manufacturing market due to several factors, including the presence of leading biotechnology and pharmaceutical companies, a supportive regulatory framework towards clinical trials and commercialization of stem cell manufacturing, robust research and development (R&D) infrastructure, and the rising demand for regenerative medicine therapies in the region.
  • Competitive Landscape: Some of the major market players in the stem cell manufacturing industry include Anterogen Co. Ltd., Becton Dickinson and Company, Bio-Rad Laboratories Inc., Bio-Techne Corporation, Corning Incorporated, FUJIFILM Holdings Corporation, Lonza Group AG, Merck KGaA, Sartorius AG, Takara Bio Inc., and Thermo Fisher Scientific Inc., among many others.
  • Challenges and Opportunities: Government initiatives to boost the biotechnology and biopharmaceutical industries represent a significant opportunity for the market. Initiatives, such as grants, tax incentives, and subsidies, aim to promote R&D, attract investments, adopt advanced technologies, and accelerate scientific discoveries and innovations in therapies and treatments. However, the market also faces a significant challenge like technical limitations associated with manufacturing scale-up, which will require companies specialized equipment and infrastructure to overcome.

Stem Cell Manufacturing Market Trends:

Increasing Investments in Stem Cell Research and Regenerative Medicine

The global stem cell manufacturing market is experiencing a significant upsurge due to the substantial investments pouring into stem cell research and regenerative medicine. Governments and private organizations are channeling resources toward these fields, recognizing their potential to revolutionize healthcare. This driver is fueled by the promising prospects of stem cell therapies in addressing previously untreatable conditions, such as neurodegenerative diseases and spinal cord injuries. For instance, an article published in the New England Journal of Medicine in August 2023 revealed the anticipated potential of stem cell gene therapy in treating Sickle Cell Disease (SCD). These investments support cutting-edge research, the development of advanced manufacturing techniques, and the expansion of clinical trials. For example, in September 2021, LifeCell International Pvt. Ltd received an investment of INR 225 crore (USD 27.2 million) from OrbiMed Asia Partners IV to further leverage its technological expertise and wide network to foray into adjacent new categories like fertility health and cell-based therapeutics. Moreover, in November 2023, ACROBiosystems Inc., a US-based company specializing in recombinant proteins and essential reagents, launched GM-grade DLL4 protein, a soluble form of Delta-like Ligand 4 (DLL4), crucial in stem cell development and differentiation.

Rising Prevalence of Chronic Diseases and the Demand for Innovative Treatments

Another vital driver propelling the global stem cell manufacturing market is the escalating prevalence of chronic diseases. Conditions like diabetes, heart disease, and autoimmune disorders are on the rise, necessitating novel and effective treatments. Stem cell therapies hold immense promise in addressing these ailments by regenerating damaged tissues and organs. For instance, in March 2021, Vertex Pharmaceuticals received FDA grant as a fast track designation to VX-880, a human stem-cell derived therapy for patients with Type-1 diabetes. Moreover, as per the December 2022 data provided by the US Food and Drug Administration (FDA), there are over 7,000 rare diseases that affect more than 30 million people in the United States. The prevalence of chronic diseases rises with age, and stem cell manufacturing exhibits promise in combating these conditions. For example, a World Health Organization factsheet from October 2021 projects that globally there will be 1.4 billion people over the age of 65 by 2030 and this number is expected to double at 2.2 billion by 2050.

Advancements in Biotechnology and Cell Culture Techniques

Advancements in biotechnology and cell culture techniques are revolutionizing the field of stem cell manufacturing. This driver is pivotal in enhancing the efficiency and scalability of stem cell production. Breakthroughs in cell culture technology, such as 3D cell culture systems and bioreactors, enable the cultivation of high-quality stem cells in larger quantities. Additionally, innovations in genetic editing techniques, like CRISPR-Cas9, offer precise control over stem cell characteristics, further expanding their therapeutic potential. These advancements not only streamline the manufacturing process but also ensure the safety and quality of stem cell-based therapies, instilling confidence among healthcare professionals and patients alike. For instance, in September 2021, Cellino, a US-based biotech company with specialization in stem cell manufacturing, presented how its system integrates AI, machine learning, and lasers, along with other hardware and software, to enhance yields and reduce production costs.

Stem Cell Manufacturing Market Segmentation:

Breakup by Product:

  • Consumables
    • Culture Media
    • Others
  • Instruments
    • Bioreactors and Incubators
    • Cell Sorters
    • Others
  • Stem Cell Lines
    • Hematopoietic Stem Cells (HSC)
    • Mesenchymal Stem Cells (MSC)
    • Induced Pluripotent Stem Cells (iPSC)
    • Embryonic Stem Cells (ESC)
    • Neural Stem Cells (NSC)
    • Multipotent Adult Progenitor Stem Cells

Consumables dominate the market

The consumables segment within the stem cell manufacturing market is experiencing robust growth due to the increasing adoption of stem cell-based research and therapies, necessitating a constant supply of consumables, including cell culture media, reagents, and growth factors. As research in this field expands, so does the demand for these essential materials. Moreover, the growing number of stem cell clinical trials and applications in regenerative medicine fuels the consumption of consumables. Clinical research and therapy development require a consistent and reliable source of high-quality consumables to ensure the safety and efficacy of stem cell-based treatments. In line with this, technological advancements in the production of consumables are driving growth.

Breakup by Application:

  • Research Applications
    • Life Science Research
    • Drug Discovery and Development
  • Clinical Application
    • Allogenic Stem Cell Therapy
    • Autologous Stem Cell Therapy
  • Cell and Tissue Banking Applications

Research applications dominate the market

The growth of the research applications segment within the stem cell manufacturing market is underpinned by the relentless pursuit of scientific knowledge and breakthrough discoveries in stem cell biology. Stem cells serve as essential tools for investigating various biological processes, disease mechanisms, and potential therapeutic avenues. Researchers across diverse fields, including regenerative medicine, developmental biology, and drug development, rely on stem cells to advance their studies. Moreover, the increasing funding and grants allocated to stem cell research bolster this segment's growth. Governments, private institutions, and non-profit organizations recognize the transformative potential of stem cell research and provide financial support to drive innovation. Additionally, technological advancements in stem cell culture techniques, genetic editing, and cell characterization tools enhance the efficiency and accuracy of research applications. These advancements enable researchers to work with a broader range of stem cell types and manipulate them with precision, further expanding the scope of research possibilities. For instance, in May 2023, Sernova announced research collaboration with AstraZeneca to evaluate novel potential therapeutic cell applications.

Breakup by End User:

  • Pharmaceutical & Biotechnology Companies
  • Academic Institutes, Research Laboratories and Contract Research Organizations
  • Hospitals and Surgical Centers
  • Cell and Tissue banks
  • Others

Pharmaceutical & biotechnology companies dominate the market

The growth of pharmaceutical and biotechnology companies is propelled by the continuous expansion of the global population and the aging demographic trends. With an aging population, the demand for healthcare services, medications, and innovative therapies rises, providing a substantial market for pharmaceutical and biotechnology companies to cater to. Moreover, the increasing prevalence of chronic diseases, including cardiovascular disorders, cancer, and diabetes, necessitates ongoing research and the development of new pharmaceutical solutions. These companies play a pivotal role in creating advanced drugs and therapies to combat these health challenges. Furthermore, advancements in biotechnology, including gene therapy, precision medicine, and biopharmaceuticals, are shaping the industry.

Breakup by Region:

  • North America
    • United States
    • Canada
  • Asia-Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Indonesia
    • Others
  • Europe
    • Germany
    • France
    • United Kingdom
    • Italy
    • Spain
    • Russia
    • Others
  • Latin America
    • Brazil
    • Mexico
    • Others
  • Middle East and Africa

North America exhibits a clear dominance, accounting for the largest stem cell manufacturing market share

The market research report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, North America accounted for the largest market share.

The North American region is experiencing robust growth in the stem cell manufacturing market, propelled by the substantial government funding and private investments in stem cell research and regenerative medicine. These financial commitments support cutting-edge research, clinical trials, and the development of advanced manufacturing techniques. Moreover, the prevalence of chronic diseases, such as diabetes, heart disease, and neurodegenerative disorders, is on the rise in North America. Stem cell therapies offer innovative solutions to address these conditions, fueling demand for their production. In line with this, the region boasts a highly developed biotechnology sector, leading to significant advancements in cell culture techniques and bioprocessing technologies. This ensures efficient and scalable stem cell production, strengthening the industry's foothold in North America. Furthermore, regulatory frameworks in North America provide a conducive environment for stem cell research and clinical trials, fostering growth and innovation. Collaborative efforts between academic institutions and industry players, along with growing public awareness of the potential of stem cell-based treatments, are additional drivers.

Competitive Landscape:

  • The market research report has also provided a comprehensive analysis of the competitive landscape in the market. Detailed profiles of all major companies have also been provided. Some of the major market players in the Stem Cell Manufacturing industry include Anterogen Co. Ltd., Becton Dickinson and Company, Bio-Rad Laboratories Inc., Bio-Techne Corporation, Corning Incorporated, FUJIFILM Holdings Corporation, Lonza Group AG, Merck KGaA, Sartorius AG, Takara Bio Inc., and Thermo Fisher Scientific Inc., among many others.

(Please note that this is only a partial list of the key players, and the complete list is provided in the report.)

  • The competitive landscape within the global stem cell manufacturing market is characterized by a dynamic interplay of numerous players, each vying to establish their prominence and contribute to the industry's growth. These entities span a spectrum of organizations, including research institutions, biotechnology companies, pharmaceutical giants, and contract manufacturing organizations. Their diverse backgrounds and resources contribute to a multifaceted ecosystem that fosters innovation and advancements in stem cell manufacturing. Key competitive strategies encompass research and development efforts to enhance manufacturing processes, scale up production, and improve the quality and safety of stem cell-based therapies. Additionally, partnerships and collaborations between these players are common, facilitating knowledge sharing and the development of cutting-edge technologies. For instance, in June 2021, Catalent, in a strategic move, acquired RheinCell Therapeutics Gmbh for an undisclosed amount to expand the creation of advanced cell treatments, thereby enhancing Catalent's capacity for large-scale production. Regulatory compliance and adherence to ethical standards are pivotal in maintaining credibility within the market. Moreover, market participants often engage in marketing and educational initiatives to increase awareness of stem cell therapies among healthcare professionals and the public, further expanding their reach.

Key Questions Answered in This Report

  • 1.What was the size of the global stem cell manufacturing market in 2024?
  • 2.What is the expected growth rate of the global stem cell manufacturing market during 2025-2033?
  • 3.What are the key factors driving the global stem cell manufacturing market?
  • 4.What has been the impact of COVID-19 on the global stem cell manufacturing market?
  • 5.What is the breakup of the global stem cell manufacturing market based on product?
  • 6.What is the breakup of the global stem cell manufacturing market based on the application?
  • 7.What is the breakup of the global stem cell manufacturing market based on the end user?
  • 8.What are the key regions in the global stem cell manufacturing market?
  • 9.Who are the key players/companies in the global stem cell manufacturing market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Stem Cell Manufacturing Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Product

  • 6.1 Consumables
    • 6.1.1 Market Trends
    • 6.1.2 Key Segments
      • 6.1.2.1 Culture Media
      • 6.1.2.2 Others
    • 6.1.3 Market Forecast
  • 6.2 Instruments
    • 6.2.1 Market Trends
    • 6.2.2 Key Segments
      • 6.2.2.1 Bioreactors and Incubators
      • 6.2.2.2 Cell Sorters
      • 6.2.2.3 Others
    • 6.2.3 Market Forecast
  • 6.3 Stem Cell Lines
    • 6.3.1 Market Trends
    • 6.3.2 Key Segments
      • 6.3.2.1 Hematopoietic Stem Cells (HSC)
      • 6.3.2.2 Mesenchymal Stem Cells (MSC)
      • 6.3.2.3 Induced Pluripotent Stem Cells (iPSC)
      • 6.3.2.4 Embryonic Stem Cells (ESC)
      • 6.3.2.5 Neural Stem Cells (NSC)
      • 6.3.2.6 Multipotent Adult Progenitor Stem Cells
    • 6.3.3 Market Forecast

7 Market Breakup by Application

  • 7.1 Research Applications
    • 7.1.1 Market Trends
    • 7.1.2 Key Segments
      • 7.1.2.1 Life Science Research
      • 7.1.2.2 Drug Discovery and Development
    • 7.1.3 Market Forecast
  • 7.2 Clinical Application
    • 7.2.1 Market Trends
    • 7.2.2 Key Segments
      • 7.2.2.1 Allogenic Stem Cell Therapy
      • 7.2.2.2 Autologous Stem Cell Therapy
    • 7.2.3 Market Forecast
  • 7.3 Cell and Tissue Banking Applications
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast

8 Market Breakup by End User

  • 8.1 Pharmaceutical & Biotechnology Companies
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Academic Institutes, Research Laboratories and Contract Research Organizations
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3 Hospitals and Surgical Centers
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast
  • 8.4 Cell and Tissue banks
    • 8.4.1 Market Trends
    • 8.4.2 Market Forecast
  • 8.5 Others
    • 8.5.1 Market Trends
    • 8.5.2 Market Forecast

9 Market Breakup by Region

  • 9.1 North America
    • 9.1.1 United States
      • 9.1.1.1 Market Trends
      • 9.1.1.2 Market Forecast
    • 9.1.2 Canada
      • 9.1.2.1 Market Trends
      • 9.1.2.2 Market Forecast
  • 9.2 Asia-Pacific
    • 9.2.1 China
      • 9.2.1.1 Market Trends
      • 9.2.1.2 Market Forecast
    • 9.2.2 Japan
      • 9.2.2.1 Market Trends
      • 9.2.2.2 Market Forecast
    • 9.2.3 India
      • 9.2.3.1 Market Trends
      • 9.2.3.2 Market Forecast
    • 9.2.4 South Korea
      • 9.2.4.1 Market Trends
      • 9.2.4.2 Market Forecast
    • 9.2.5 Australia
      • 9.2.5.1 Market Trends
      • 9.2.5.2 Market Forecast
    • 9.2.6 Indonesia
      • 9.2.6.1 Market Trends
      • 9.2.6.2 Market Forecast
    • 9.2.7 Others
      • 9.2.7.1 Market Trends
      • 9.2.7.2 Market Forecast
  • 9.3 Europe
    • 9.3.1 Germany
      • 9.3.1.1 Market Trends
      • 9.3.1.2 Market Forecast
    • 9.3.2 France
      • 9.3.2.1 Market Trends
      • 9.3.2.2 Market Forecast
    • 9.3.3 United Kingdom
      • 9.3.3.1 Market Trends
      • 9.3.3.2 Market Forecast
    • 9.3.4 Italy
      • 9.3.4.1 Market Trends
      • 9.3.4.2 Market Forecast
    • 9.3.5 Spain
      • 9.3.5.1 Market Trends
      • 9.3.5.2 Market Forecast
    • 9.3.6 Russia
      • 9.3.6.1 Market Trends
      • 9.3.6.2 Market Forecast
    • 9.3.7 Others
      • 9.3.7.1 Market Trends
      • 9.3.7.2 Market Forecast
  • 9.4 Latin America
    • 9.4.1 Brazil
      • 9.4.1.1 Market Trends
      • 9.4.1.2 Market Forecast
    • 9.4.2 Mexico
      • 9.4.2.1 Market Trends
      • 9.4.2.2 Market Forecast
    • 9.4.3 Others
      • 9.4.3.1 Market Trends
      • 9.4.3.2 Market Forecast
  • 9.5 Middle East and Africa
    • 9.5.1 Market Trends
    • 9.5.2 Market Breakup by Country
    • 9.5.3 Market Forecast

10 SWOT Analysis

  • 10.1 Overview
  • 10.2 Strengths
  • 10.3 Weaknesses
  • 10.4 Opportunities
  • 10.5 Threats

11 Value Chain Analysis

12 Porters Five Forces Analysis

  • 12.1 Overview
  • 12.2 Bargaining Power of Buyers
  • 12.3 Bargaining Power of Suppliers
  • 12.4 Degree of Competition
  • 12.5 Threat of New Entrants
  • 12.6 Threat of Substitutes

13 Price Analysis

14 Competitive Landscape

  • 14.1 Market Structure
  • 14.2 Key Players
  • 14.3 Profiles of Key Players
    • 14.3.1 Anterogen Co. Ltd.
      • 14.3.1.1 Company Overview
      • 14.3.1.2 Product Portfolio
      • 14.3.1.3 Financials
    • 14.3.2 Becton Dickinson and Company
      • 14.3.2.1 Company Overview
      • 14.3.2.2 Product Portfolio
      • 14.3.2.3 Financials
      • 14.3.2.4 SWOT Analysis
    • 14.3.3 Bio-Rad Laboratories Inc.
      • 14.3.3.1 Company Overview
      • 14.3.3.2 Product Portfolio
      • 14.3.3.3 Financials
      • 14.3.3.4 SWOT Analysis
    • 14.3.4 Bio-Techne Corporation
      • 14.3.4.1 Company Overview
      • 14.3.4.2 Product Portfolio
      • 14.3.4.3 Financials
    • 14.3.5 Corning Incorporated
      • 14.3.5.1 Company Overview
      • 14.3.5.2 Product Portfolio
      • 14.3.5.3 Financials
      • 14.3.5.4 SWOT Analysis
    • 14.3.6 FUJIFILM Holdings Corporation
      • 14.3.6.1 Company Overview
      • 14.3.6.2 Product Portfolio
      • 14.3.6.3 Financials
    • 14.3.7 Lonza Group AG
      • 14.3.7.1 Company Overview
      • 14.3.7.2 Product Portfolio
      • 14.3.7.3 Financials
      • 14.3.7.4 SWOT Analysis
    • 14.3.8 Merck KGaA
      • 14.3.8.1 Company Overview
      • 14.3.8.2 Product Portfolio
      • 14.3.8.3 Financials
    • 14.3.9 Sartorius AG
      • 14.3.9.1 Company Overview
      • 14.3.9.2 Product Portfolio
      • 14.3.9.3 Financials
    • 14.3.10 Takara Bio Inc.
      • 14.3.10.1 Company Overview
      • 14.3.10.2 Product Portfolio
      • 14.3.10.3 Financials
    • 14.3.11 Thermo Fisher Scientific Inc.
      • 14.3.11.1 Company Overview
      • 14.3.11.2 Product Portfolio
      • 14.3.11.3 Financials
      • 14.3.11.4 SWOT Analysis

List of Figures

  • Figure 1: Global: Stem Cell Manufacturing Market: Major Drivers and Challenges
  • Figure 2: Global: Stem Cell Manufacturing Market: Sales Value (in Billion USD), 2019-2024
  • Figure 3: Global: Stem Cell Manufacturing Market Forecast: Sales Value (in Billion USD), 2025-2033
  • Figure 4: Global: Stem Cell Manufacturing Market: Breakup by Product (in %), 2024
  • Figure 5: Global: Stem Cell Manufacturing Market: Breakup by Application (in %), 2024
  • Figure 6: Global: Stem Cell Manufacturing Market: Breakup by End User (in %), 2024
  • Figure 7: Global: Stem Cell Manufacturing Market: Breakup by Region (in %), 2024
  • Figure 8: Global: Stem Cell Manufacturing (Consumables) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 9: Global: Stem Cell Manufacturing (Consumables) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 10: Global: Stem Cell Manufacturing (Instruments) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 11: Global: Stem Cell Manufacturing (Instruments) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 12: Global: Stem Cell Manufacturing (Stem Cell Lines) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 13: Global: Stem Cell Manufacturing (Stem Cell Lines) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 14: Global: Stem Cell Manufacturing (Research Applications) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 15: Global: Stem Cell Manufacturing (Research Applications) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 16: Global: Stem Cell Manufacturing (Clinical Application) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 17: Global: Stem Cell Manufacturing (Clinical Application) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 18: Global: Stem Cell Manufacturing (Cell and Tissue Banking Applications) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 19: Global: Stem Cell Manufacturing (Cell and Tissue Banking Applications) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 20: Global: Stem Cell Manufacturing (Pharmaceutical & Biotechnology Companies) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 21: Global: Stem Cell Manufacturing (Pharmaceutical & Biotechnology Companies) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 22: Global: Stem Cell Manufacturing (Academic Institutes, Research Laboratories and Contract Research Organizations) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 23: Global: Stem Cell Manufacturing (Academic Institutes, Research Laboratories and Contract Research Organizations) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 24: Global: Stem Cell Manufacturing (Hospitals and Surgical Centers) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 25: Global: Stem Cell Manufacturing (Hospitals and Surgical Centers) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 26: Global: Stem Cell Manufacturing (Cell and Tissue banks) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 27: Global: Stem Cell Manufacturing (Cell and Tissue banks) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 28: Global: Stem Cell Manufacturing (Other End Users) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 29: Global: Stem Cell Manufacturing (Other End Users) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 30: North America: Stem Cell Manufacturing Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 31: North America: Stem Cell Manufacturing Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 32: United States: Stem Cell Manufacturing Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 33: United States: Stem Cell Manufacturing Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 34: Canada: Stem Cell Manufacturing Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 35: Canada: Stem Cell Manufacturing Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 36: Asia-Pacific: Stem Cell Manufacturing Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 37: Asia-Pacific: Stem Cell Manufacturing Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 38: China: Stem Cell Manufacturing Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 39: China: Stem Cell Manufacturing Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 40: Japan: Stem Cell Manufacturing Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 41: Japan: Stem Cell Manufacturing Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 42: India: Stem Cell Manufacturing Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 43: India: Stem Cell Manufacturing Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 44: South Korea: Stem Cell Manufacturing Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 45: South Korea: Stem Cell Manufacturing Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 46: Australia: Stem Cell Manufacturing Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 47: Australia: Stem Cell Manufacturing Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 48: Indonesia: Stem Cell Manufacturing Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 49: Indonesia: Stem Cell Manufacturing Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 50: Others: Stem Cell Manufacturing Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 51: Others: Stem Cell Manufacturing Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 52: Europe: Stem Cell Manufacturing Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 53: Europe: Stem Cell Manufacturing Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 54: Germany: Stem Cell Manufacturing Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 55: Germany: Stem Cell Manufacturing Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 56: France: Stem Cell Manufacturing Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 57: France: Stem Cell Manufacturing Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 58: United Kingdom: Stem Cell Manufacturing Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 59: United Kingdom: Stem Cell Manufacturing Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 60: Italy: Stem Cell Manufacturing Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 61: Italy: Stem Cell Manufacturing Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 62: Spain: Stem Cell Manufacturing Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 63: Spain: Stem Cell Manufacturing Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 64: Russia: Stem Cell Manufacturing Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 65: Russia: Stem Cell Manufacturing Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 66: Others: Stem Cell Manufacturing Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 67: Others: Stem Cell Manufacturing Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 68: Latin America: Stem Cell Manufacturing Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 69: Latin America: Stem Cell Manufacturing Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 70: Brazil: Stem Cell Manufacturing Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 71: Brazil: Stem Cell Manufacturing Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 72: Mexico: Stem Cell Manufacturing Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 73: Mexico: Stem Cell Manufacturing Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 74: Others: Stem Cell Manufacturing Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 75: Others: Stem Cell Manufacturing Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 76: Middle East and Africa: Stem Cell Manufacturing Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 77: Middle East and Africa: Stem Cell Manufacturing Market: Breakup by Country (in %), 2024
  • Figure 78: Middle East and Africa: Stem Cell Manufacturing Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 79: Global: Stem Cell Manufacturing Industry: SWOT Analysis
  • Figure 80: Global: Stem Cell Manufacturing Industry: Value Chain Analysis
  • Figure 81: Global: Stem Cell Manufacturing Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Stem Cell Manufacturing Market: Key Industry Highlights, 2024 and 2033
  • Table 2: Global: Stem Cell Manufacturing Market Forecast: Breakup by Product (in Million USD), 2025-2033
  • Table 3: Global: Stem Cell Manufacturing Market Forecast: Breakup by Application (in Million USD), 2025-2033
  • Table 4: Global: Stem Cell Manufacturing Market Forecast: Breakup by End User (in Million USD), 2025-2033
  • Table 5: Global: Stem Cell Manufacturing Market Forecast: Breakup by Region (in Million USD), 2025-2033
  • Table 6: Global: Stem Cell Manufacturing Market: Competitive Structure
  • Table 7: Global: Stem Cell Manufacturing Market: Key Players